Kelly Lawrence W & Associates’s Kyndryl KD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-181
Closed -$6.26K 171
2024
Q4
$6.26K Sell
181
-160
-47% -$4.66K ﹤0.01% 148
2024
Q3
$7.84K Hold
341
﹤0.01% 148
2024
Q2
$8.97K Buy
341
+160
+88% +$3.83K ﹤0.01% 150
2024
Q1
$3.94K Hold
181
﹤0.01% 163
2023
Q4
$3.76K Hold
181
﹤0.01% 157
2023
Q3
$2.73K Hold
181
﹤0.01% 153
2023
Q2
$2.41K Hold
181
﹤0.01% 148
2023
Q1
$2.67K Hold
181
﹤0.01% 152
2022
Q4
$2.01K Hold
181
﹤0.01% 154
2022
Q3
$1K Hold
181
﹤0.01% 171
2022
Q2
$2K Buy
181
+1
+0.6% +$12 ﹤0.01% 169
2022
Q1
$2K Hold
180
﹤0.01% 158
2021
Q4
$3K Buy
+180
New +$3.89K ﹤0.01% 162

Other funds holding KD

Kelly Lawrence W & Associates's KD Position: Q1 2025 in Review

Kelly Lawrence W & Associates sold out of Kyndryl (KD) in Q1 2025, closing a stake of 181 shares — an estimated $6.26K sold.

Kelly Lawrence W & Associates first reported a position in KD in Q4 2021 and held it in 13 quarters. The position peaked at $8.97K in Q2 2024. 702 funds tracked by Wall St. Rank hold KD as of Q1 2025.

  • Kelly Lawrence W & Associates reported no remaining Kyndryl position as of Q1 2025 after selling out during the quarter.
  • Kelly Lawrence W & Associates sold 181 Kyndryl shares in Q1 2025, an estimated $6.26K.
  • Kelly Lawrence W & Associates first reported a position in Kyndryl in Q4 2021 and held it in 13 quarters.
  • Kelly Lawrence W & Associates's Kyndryl position peaked at $8.97K in Q2 2024.
  • 702 funds tracked by Wall St. Rank held Kyndryl as of Q1 2025.

Based on Kelly Lawrence W & Associates's 13F filing for Q1 2025, filed 14 May 2025.